Elvira P. Yanysheva

Ms. Elvira P. Yanysheva

orcid

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
9 May 2024 in Cells
Verified
Journal Article
Open access
PDF file
ABAleksandra S. Bugakova
Aleksandra S. Bugakova
Daria ChudakovaDaria Chudakova
Daria Chudakova
MMMaria Myzina
Maria Myzina
EYElvira P. Yanysheva
Elvira P. Yanysheva
IOIuliia Ozerskaya
Iuliia Ozerskaya
GYGaukhar Yusubalieva
Gaukhar Yusubalieva
Glioblastoma (GBM) is the most common malignancy of the central nervous system in adults. GBM has high levels of therapy failure and its prognosis is usually dismal. The phenotypic heterogeneity of the tumor cells, dynamic complexity of non-tumor cell populations within the GBM tumor microenvironment (TME), and their bi-directional cross-talk contribute to the challenges of current therapeutic approaches. Herein, we discuss the etiology of GBM, and describe several major types of non-tumor cells within its TME, their impact on GBM pathogenesis, and molecular mechanisms of such an impact. We also discuss their value as potential therapeutic targets or prognostic biomarkers, with reference to the most recent works on this subject. We conclude that unless all “key player” populations of non-tumor cells within the TME are considered, no breakthrough in developing treatment for GBM can be achieved.

28 February 2025 in Sovremennye tehnologii v medicine
Verified
Journal Article
Open access
EYElvira P. Yanysheva
Elvira P. Yanysheva
PMP.A. Melnikov
P.A. Melnikov
DCD.A. Chudakova
D.A. Chudakova
MSM.V. Shirmanova
M.V. Shirmanova
VBV.P. Baklaushev
V.P. Baklaushev
GYG.M. Yusubalieva
G.M. Yusubalieva
The study was performed using the C57Bl/6-FoxP3-eGFP mouse strain, which allows for the detection of FoxP3-positive Tregs by fluorescent signal. Orthotopic glioblastomas were implanted by stereotactic injection of fluorescently labeled GL-261-BFP and GL-261-mScarlet tumor cell lines. Intravital confocal microscopy was used to monitor infiltration of the tumor site by immune cells, visualized by intravenous injection of fluorescently labeled antibodies against CD45. The results of intravital microscopy were confirmed by histological and immunohistochemical examination on days 3, 6, 9, 14, and 16 after the implantation. To assess the immunological status, tumor-infiltrating lymphocytes (TILs) were isolated from the brain and Tregs were counted using a flow cytometer (immediately after isolation and after cultivation for 2 weeks). Intravital microscopy and brain slice studies have demonstrated infiltration of the glioblastoma site by Tregs, with the proportion of Tregs increasing with tumor progression (the increase in the absolute number of Treg was proportional to the increase in the number of glioma cells). Subsequent co-cultivation of isolated TILs with glioma cells revealed increase of Treg population within 2 weeks from 2.8% to >40%, confirming the activating effect of glioblastoma with respect to Tregs. The dynamics of GL-261 glioma microenvironment infiltration by Tregs has been investigated. The glioblastoma cells were shown to activate Tregs in the peritumor space in vivo and to promote their selective expansion when co-cultured with TILs in vitro. These data can be used for further studies on C57Bl/6-FoxP3-eGFP mice to find approaches to inactivate Tregs in glioblastoma.

26 June 2025 in Extreme Medicine
Verified
Journal Article
Open access
PDF file
EYElvira P. Yanysheva
Elvira P. Yanysheva
VBVladimir P. Baklaushev
Vladimir P. Baklaushev
GYGaukhar Yusubalieva
Gaukhar Yusubalieva
Роль регуляторных Т-лимфоцитов в формировании иммуносупрессивного микроокружения при глиобластоме

4 December 2025 in Biomedicines
Verified
Journal Article
Open access
PDF file
GYGaukhar Yusubalieva
Gaukhar Yusubalieva
Daria ChudakovaDaria Chudakova
Daria Chudakova
PSPolina Shirokikh
Polina Shirokikh
DYDiana V. Yuzhakova
Diana V. Yuzhakova
Elena KiselevaElena Kiseleva
Elena Kiseleva
VBVladimir P. Baklaushev
Vladimir P. Baklaushev
Background/Objectives: Glioblastoma (GBM) is an aggressive primary brain tumor with dismal prognosis and limited treatment options. Immunotherapy, including personalized approaches using tumor-infiltrating lymphocytes (TILs) and allogeneic natural (NK) or engineered killer cells (chimeric antigen receptor NK, NK-CAR), and oncolytic viruses (OV), has shown some potential in GBM. Combining different therapeutic strategies may enhance treatment efficacy. Here, we present a xenograft GBM mouse model with multiparametric detection for various immunotherapy research applications. Methods: In a xenograft GBM NOD-Prkdcs scid Il2rgem1/Smoc (NSG) mouse model based on orthotopic transplantation of patient-derived GBM cultures retaining tumor heterogeneity, intravenous and intratumor immunotherapeutic interventions by TIL and OV therapy were performed. Xenograft engraftment was evaluated using intravital MRI; delivery of OV and TILs to the tumor and changes in the tumor and peritumoral space were assessed using intravital confocal microscopy; and metabolic and structural changes in the tumor and peritumoral environment were assessed via fluorescence lifetime imaging microscopy (FLIM) and optical coherence tomography (OCT). The intravital imaging data were compared with the results of preliminary and final histological and immunocytochemical data. Results: Both OV and TILs demonstrated tumor-specific targeting and delivery across the blood–brain barrier. Further, we showed that in this model the xenograft response to both therapeutic treatments can be assessed using FLIM and OCT. Conclusions: Overall, this work presents an optimized mouse model suitable for assessing the effect of combined TIL immunotherapy and OV on GBM in translational studies.